Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-004986
Filing Date
2020-01-27
Accepted
2020-01-27 16:13:54
Documents
1
Period of Report
2020-01-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3326
  Complete submission text file 0001209191-20-004986.txt   4810
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Issuer) CIK: 0000827871 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 TICE BLVD., SUITE 315 C/O EAGLE PHARMACEUTICALS WOODCLIFF LAKE NJ 07677
Business Address
Hepner Adrian (Reporting) CIK: 0001637347 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36306 | Film No.: 20549679